Medtechtomarket developed a wireless ECG device for use by professionals in primary, acute and hyper-acute care settings for the measurement of cardiac arrhythmias and morphological conditions.Read full case study
There are approximately 123,000 cases of sepsis per year in England and around 46,000 associated deaths – of which 70% of cases come from the community and directly cost the NHS at least 1.5bn each year. Medtechtomarket led the development of a low cost rapid microfluidic diagnostic system for the early detection of Sepsis, winning two significant SBRI awards and demonstrating correlations with competitor laboratory systems of > 0.99 on biochemical markers of sepsis. We started with input from a clinical advisory and academic panel, Medtechtomarket developed and patented a prototype portable microfluidic multi-assay system for a range of clinical applications including early detection of sepsis.
Medtechtomarket has been awarded 2 prestigious SBRI awards to support the development of the product for use in Primary care. Our in-house advanced manufacturing facility has enabled the automated pico-Litre dispensing of reagents into the microfluidic device. Medtechtomarket has utilised BioBank samples to confirm initial product applicability.